Teppei Obara - Publications

Predictors of the Overall Survival with Azacitidine Monotherapy in Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Therapy.

Journal: Internal medicine (Tokyo, Japan)

Published: July 24, 2022

Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.

Journal: Journal of medical case reports

Published: June 01, 2022

Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies.

Journal: Annals of hematology

Published: February 24, 2022

Addition of plerixafor for mobilization of stem cells with bortezomib is feasible in dialysis-dependent multiple myeloma.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: September 03, 2021

Azacitidine for the treatment of patients with relapsed acute myeloid leukemia after allogeneic stem cell transplantation.

Journal: Leukemia & lymphoma

Published: June 23, 2021

A human SIRPA knock-in xenograft mouse model to study human hematopoietic and cancer stem cells.

Journal: Blood

Published: June 28, 2019

Cardiac metastasis of squamous cell carcinoma of the thyroid gland with severe disseminated intravascular coagulation: A case report.

Journal: Molecular and clinical oncology

Published: August 29, 2016

Chronic myelomonocytic leukemia blast crisis in a patient with advanced non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors.

Journal: Respiratory investigation

Published: July 26, 2016